Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 6, 2014

View Archived Issues

Anti-LFA-1A antibody with utility for targeting alloreactive T cells in kidney allografts

Astellas Pharma profiles pipeline developments of first quarter of fiscal 2014

Daya Drug Discoveries profiles novel non-opioid, non-cannabinoid analgesic

ANI Pharmaceuticals acquires vancomycin assets from Shire

Bristol-Myers Squibb forms joint venture to advance development of U.S. academic discoveries

Ignyta licenses two first-in-class kinase inhibitors from Nerviano

Evolva acquires Prosarix

Cellular Biomedicine Group to acquire Agreen Biotech

Regen BioPharma advances development of dCellVax

Conditional marketing authorization in E.U. for Translarna in Duchenne muscular dystrophy

T-923 enhances the efficacy of CoB-based strategies and promotes transplant tolerance

Novel MAbs for cancer disclosed by Metheresis Translational Research

Merck KGaA prepares new cathepsin D inhibitors

New heterocyclic compounds patented by group in China

Lupin divulges novel nAChR alpha7 modulators

Yuhan reports novel glucokinase activators

NanoViricides to restart anti-Ebola virus drug program

AB-103 granted orphan product status in the E.U. for soft tissue infections

Neuraceq launched in Germany

Phase III ASPIRE trial of Kyprolis meets primary endpoint

Aegis Therapeutics seeks partnering for exenatide nasal spray

Octapharma's Nuwiq receives E.U. approval for hemophilia A

Moerae Matrix begins phase I trial of MMI-0100 for idiopathic pulmonary fibrosis

Novimmune completes phase I trial of NI-0101

Rogne Bioscience in-licenses anti-inflammatory peptide for development as psoriasis drug

Japanese approval sought for monotherapy use of E Keppra Intravenous Drip Infusion

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...